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INTRODUCTION 
Cultured  cells cloned  from  the  C1300  neuroblas- 
toma  have been  shown  by  several  laboratories  to 
extend  neurites  (1-6)  and  to  accumulate  nerve- 
specific enzymatic activities (7) when grown under 
conditions in which cell division is inhibited. Study 
of this system has been stimulated by the hope that 
it  might  serve  as  an  in  vitro  model  of nerve  cell 
differentiation.  Many  of  the  neurite-inducing 
agents,  including  serum  deprivation  (3),  prosta- 
glandins  (4),  theophylline  (5),  and  analogues  of 
cAMP 1 including dibutyryl cAMP (B~cAMP), are 
thought to act principally by raising the intracellu- 
lar concentrations  of cAMP.  Division is inhibited 
in  all  these  cases,  as  well  as  in  non-neural  cell 
cultures treated  with cAMP analogues (8). 
The observed stimulation of neurite extension in 
cAMP-treated  neuroblastoma  cultures  might  be 
explained  in  either  of  two  ways.  The  "direct" 
explanation  is that cAMP itself stimulates neurite 
outgrowth,  and  inhibits  division  only  coinciden- 
tally.  The  "indirect"  hypotheses  maintains  that 
since  neurites  grow during  interphase  and  are  re- 
tracted  during  mitosis (3),  cAMP permits neurite 
extension  by  stopping  the cell cycle in interphase. 
The  action  of  cAMP  under  either  hypothesis 
might  or  might  not  require  interaction  with  or 
alteration  of nuclear activity. 
We  report  here that  enucleated  neuroblastoma 
1Abbreviations used in  this paper: B2cAMP,  dibutryl 
cAMP;  cAMP,  adenosine  3'-5'cyclic monophosphoric 
acid; CB, cytochalasin  B; cGMP, guanosine 3'-5'cyclic 
monophosphoric  acid;  CHO,  Chinese  hamster  ovary 
cells. 
cells extend  neurites  when treated  with  B~cAMP. 
Our  results  demonstrate  that  at  least  the  early 
stages  of neurite  extension  do  not  require  altera- 
tion of intranuclear events, and add support to the 
"direct" explanation of cAMP-induced neuroblas- 
toma differentiation. 
MATERIALS  AND  METHODS 
Materials 
Serum  and  tissue  culture  media were obtained  from 
Grand  Island  Biological  Co.,  Grand  Island,  N.  Y., 
plasticware from Falcon Plastics, Div. of B.-D.  Labora- 
tories, Los Angeles, Calif., B2cAMP, cGMP and butyric 
acid from Sigma Chemical Corp., St.  Louis, Mo.,  and 
cytochalasin  B from  Aldrich Chemical Co.,  Inc.,  Mil- 
waukee, Wis. 
Cell Line 
Clone Neuro-2a, derived from the spontaneous mouse 
C1300  neuroblastoma  by  Klebe  and  Ruddle  (9),  was 
grown  in  commercially treated  plastic  flasks  in  Dul- 
becco-Vogt modified Eagle's medium containing 8-10% 
gamma globulin-free newborn calf serum and antibiotics 
under 10% CO2 at 37°C. Cultures were passaged  weekly. 
Enucleation 
Cells were enucleated by a  modification of the tech- 
nique of Prescott et al. (10). Plastic disks were cut from 
the  bottoms  of tissue  culture  dishes,  sterilized  by  UV 
irradiation, and placed into 2 ml of growth medium.  1-3 
×  105  cells  were  then  added  and  allowed  to  attach 
overnight. Cytochalasin B (CB) was then added to a final 
concentration  of  10 #g/ml from  a  stock  solution  of  1 
mg/ml in dimethyl sulfoxide.  After 1 h of incubatiQa  St 
37°C, the disks were placed into sterile centrifuge tubes 
containing 8 ml of growth medium and 2.5 t~g/ml of CB, 
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and  were centrifuged for  l0 min at 7000-9000 g  in an 
RC-2B  centrifuge  using  an  SS-34  rotor  prewarmed  to 
37°C. This lower concentration of CB was  used  for the 
centrifugation step because the cells detached from the 
plastic disk if spun at a higher concentration of the drug. 
Centrifugation of the CB-treated cells caused  the nuclei 
to  separate  from  the  cytoplasmic  residues,  which  re- 
mained attached to the plastic.  Giemsa-stained prepara- 
tions  usually  contained  85  95%  enucleated cells;  disks 
less satisfactory than this were not used  for analysis. 
After the centrifugation, the disks were washed  twice 
in drug-free Hanks salt solution,  placed into 2 ml of fresh 
growth medium, and incubated for 1 h to permit recovery 
from the effects of the CB. At this point (see Fig.  1), one 
group  of  disks  was  fixed  in  3:1  ethanol-acetic  acid, 
stained  in Fisher's Giemsa, washed three times in Gurr's 
buffer (pH 6.8), and air dried. These cultures served as a 
pretreatment control. A second  group was treated, after 
1 h  in drug-free medium, with the agent under investiga- 
tion  (usually  1 mm  B2cAMP as described below)  for a 
period  of 4.5  h  before  fixation  and  staining.  A  third 
group,  the  drug-free  control,  was  incubated  for  the 
additional 4.5 h in growth medium alone. The incubation 
period  we  used,  4.5  h,  was  sufficient  to  permit  the 
drug-induced morphological alterations.  Longer incuba- 
tion  times  were  not  so  instructive,  because  of  the 
morphological  degeneration  which  occurred  even  in 
control cytoplasms upon longer (e.g.,  12-h) incubation. 
Scoring of Morphology 
After staining, random microscope fields were photo- 
graphed and then evaluated by scorers who were blind to 
the  treatment  conditions.  Randomly  chosen  cells  (no 
more than  5 per field  and 40 per disk) were scored  for 
number of neurites, with a neurite defined arbitrarily as 
an extension from the cell body longer than the average 
diameter  of that  soma.  Cells  which  had  at  least  one 
neurite  were also  scored  for neurite  length,  branching, 
and extent of neurite varicosity formation. 
RESULTS 
The clone of neuroblastoma  cells which  was used 
in  our  experiments,  Neuro-2a,  is  highly  pleo- 
morphic  in  logarithmic  growth.  A  given  culture 
always contains, in close proximity, dividing round 
cells,  flat  cells without  processes,  and  cells which 
possess  neurite-like extensions which vary consid- 
erably  in  length  and  complexity.  Similarly,  cells 
which have been enucleated and allowed to recover 
for  1 h  in growth  medium (pretreatment  controls, 
as  described  above)  showed  a  wide  spectrum  of 
morphologic  types.  A  representative  field  is  pre- 
sented in Fig. 2 a. Cells which were incubated  for 
an  additional  4.5  h  in  the  absence  of added  drug 
(drug-free  controls)  appeared  similar  to  the  pre- 
treatment  cells  (Fig.  2  b).  Addition  of  1  mM 
B2cAMP  at  the  beginning  of  this  4.5-h  period, 
however,  seemed  to  increase  the  number,  length, 
and  complexity  of the  neuronal  processes  in  the 
culture (Fig.  2 c). 
Since  this  morphological  change  produced  by 
B~cAMP did not occur in every enucleated Neuro- 
2a  cell  in  a  given  population,  we  undertook 
statistical  analysis  to  test  our  initial  impressions. 
Table I demonstrates that the fraction of cells with 
at  least  one  neurite  is  significantly greater  in  the 
B~cAMP-treated  cells  than  in  either  of  the  two 
controls. 
B~cAMP-treated  cells  also  differed  from  both 
control  populations  in  that  their  neurites,  when 
present,  were longer in proportion to the cell body 
diameter,  and  contained,  on  average,  a  greater 
number of bead-like varicosities. These differences 
were statistically significant (X 2 test) at better than 
the 0.025  level. 
We have conducted  preliminary experiments to 
see  if  the  effect  of  B2cAMP  might  have  been 
mediated  by  contamination  of  the  commercial 
preparation with butyratc, as has been suggested in 
at  least  one  similar  study  (11).  In  three  separate 
experiments,  1 mM sodium butyrate in place of the 
B2cAMP produced cytoplasm morphologically in- 
distinguishable  from that of either control popula- 
tion. 
Because cGMP has been reported to antagonize 
the effects of cAMP analogues in several systems, 
including  one  system  (12)  arguably  involving mi- 
crotubule  polymerization,  we tested  the ability of 
cGMP  to  oppose  the  morphological  changes  in- 
duced  by  B2cAMP  in  neuroblastoma  cytoplasms. 
In three experiments in which cGMP was added to 
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prepared  as  described  in  text  and  in  Fig.  1.  In  (a),  pretreatment  control;  (b),  drug-free  control;  (c), 
B~cAMP-treated. The bar indicates 50 nm.  x  310. 
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Frequency of Occurrence  of Neuronal Processes  in 
Treated  and Untreated Cells 
Fraction with neurites 
Cell type 
n  No neurites  One or more 
Pretreatment  125  49 (39)  76 (61) 
Drug-free  120  45 (38)  75 (62) 
B~cAMP  150  28 (19)  122 (81) 
X  2  analysis 
Comparison 
x ~  Probability 
Pretreatment vs. drug-free  0.06  0.90 > P > 0.80 
Pretreatment vs. B2cAMP  14.26  0.00025  > P 
B2cAMP vs. dFug-free  12.07  0.0005  > P > 0.00025 
Numbers in parentheses denote percentages. 
B2cAMP-treated  cultures  in  up to fourfold molar 
excess,  neurite  extension  occurred  which  was  su- 
perficially  indistinguishable  from  that  of cultures 
treated  with  B~cAMP alone. 
DISCUSSION 
We have shown  that  the  administration  of  1 mM 
B2cAMP  to  enucleated  neuroblastoma  cells  I  h 
after enucleation causes an increase in the fraction 
of  the  cells  which  have  neurites,  compared  to 
drug-free enucleated  controls,  when  both  popula- 
tions  are examined 4.5  h  after  B~cAMP adminis- 
tration.  B2cAMP  is  not  acting  by  preventing  any 
possible  enucleation-induced  morphological 
change,  since  drug-treated  cultures  differed  from 
pretreatment  as  well  as  from  drug-free  prepara- 
tions. 
Our  results demonstrate  that  at  least the initial 
phase  of cAMP-induced  morphological  differen- 
tiation in neuroblastoma  cells can occur independ- 
ently of communication in either direction between 
the  nucleus  and  cytoplasm.  Many  laboratories 
have demonstrated that cAMP can affect cytoplas- 
mic events by altering the state of phosphorylation 
of specific proteins (reviewed in reference  13). The 
results of Langan (14) describing cAMP-mediated 
phosphorylation  of histones  render  plausible  the 
notion  that  in  some systems  cAMP may exert an 
effect  on  nuclear  synthetic  activity.  Neuroblas- 
toma transcription could conceivably be altered by 
cAMP,  but  our data  rule  out the hypothesis  that 
any such changes are necessary  in the early stages 
of morphological differentiation  in these cells. 
Since the work described above was completed, 
Schroder and  Hsie (15) have reported a  B2cAMP- 
induced  morphological  alteration  in  enucleated 
Chinese  hamster  ovary  cells,  analogous  to  the 
drug's effect on intact CHO cells. It is possible that 
a  common cytoplasmic event is occurring in both 
these  cell types,  the  particular  effect of which  is 
channeled  into neurite extension in neuroblastoma 
and elongation in CHO cells. 
The  indirect,  permissive  explanation  for  the 
stimulation  by  cAMP  analogues  of neurite  out- 
growth  has  been  weakened  by  the  findings  that 
serum  starvation  can  produce  neurite  outgrowth 
within  60  min  in  75%  of some  clonal  neuroblas- 
toma  populations  (3),  and  that  cAMP  and 
B2cAMP can produce similar morphological alter- 
ations  in  explanted  chick  spinal  root  ganglia 
despite  the  virtual  absence  of  mitosis  in  this 
preparation  (16). These last studies have, however, 
proved  difficult  to  confirm  (P.  Greengard,  per- 
sonal  communication).  Our  results  add  further 
support to the direct hypothesis. Enucleation effec- 
tively prevents  the  transition  of cells from  inter- 
phase  to  mitosis.  Our  results  show  that  regard- 
less  of the  effect  this  interruption  may  have  on 
neurite  extension,  B2cAMP  produces  additional 
outgrowth  that  cannot  now be attributable  to the 
drug's  putative  effect  on  a  cell  cycle  already 
blocked. 
Further  investigations  of the  biochemical  cor- 
relates  and  genetic  controls  of  cAMP-mediated 
neurite  extension  in  cultured  neurohlastoma  cells 
are now in progress. 
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